S. M. Shatil Shahriar, Navatha Shree Polavoram, Syed Muntazir Andrabi, Yajuan Su, Donghee Lee, Huy Quang Tran, Samantha J. Schindler, Jingwei Xie
Multiphasic scaffolds with tailored gradient features hold significant promise for tissue regeneration applications. Herein, this work reports the transformation of two-dimensional (2D) layered fiber mats into three-dimensional (3D) multiphasic scaffolds using a ‘solids-of-revolution’ inspired gas-foaming expansion technology. These scaffolds feature precise control over fiber alignment, pore size, and regional structure. Manipulating nanofiber mat layers and Pluronic F127 concentrations allows further customization of pore size and fiber alignment within different scaffold regions. The cellular response to multiphasic scaffolds demonstrates that the number of cells migrated and proliferated onto the scaffolds is mainly dependent on the pore size rather than fiber alignment. In vivo subcutaneous implantation of multiphasic scaffolds to rats reveals substantial cell infiltration, neo tissue formation, collagen deposition, and new vessel formation within scaffolds, greatly surpassing the capabilities of traditional nanofiber mats. Histological examination indicates the importance of optimizing pore size and fiber alignment for the promotion of cell infiltration and tissue regeneration. Overall, these scaffolds have potential applications in tissue modeling, studying tissue-tissue interactions, interface tissue engineering, and high-throughput screening for optimized tissue regeneration.
{"title":"Transforming layered 2D mats into multiphasic 3D nanofiber scaffolds with tailored gradient features for tissue regeneration","authors":"S. M. Shatil Shahriar, Navatha Shree Polavoram, Syed Muntazir Andrabi, Yajuan Su, Donghee Lee, Huy Quang Tran, Samantha J. Schindler, Jingwei Xie","doi":"10.1002/bmm2.12065","DOIUrl":"https://doi.org/10.1002/bmm2.12065","url":null,"abstract":"<p>Multiphasic scaffolds with tailored gradient features hold significant promise for tissue regeneration applications. Herein, this work reports the transformation of two-dimensional (2D) layered fiber mats into three-dimensional (3D) multiphasic scaffolds using a ‘solids-of-revolution’ inspired gas-foaming expansion technology. These scaffolds feature precise control over fiber alignment, pore size, and regional structure. Manipulating nanofiber mat layers and Pluronic F127 concentrations allows further customization of pore size and fiber alignment within different scaffold regions. The cellular response to multiphasic scaffolds demonstrates that the number of cells migrated and proliferated onto the scaffolds is mainly dependent on the pore size rather than fiber alignment. In vivo subcutaneous implantation of multiphasic scaffolds to rats reveals substantial cell infiltration, neo tissue formation, collagen deposition, and new vessel formation within scaffolds, greatly surpassing the capabilities of traditional nanofiber mats. Histological examination indicates the importance of optimizing pore size and fiber alignment for the promotion of cell infiltration and tissue regeneration. Overall, these scaffolds have potential applications in tissue modeling, studying tissue-tissue interactions, interface tissue engineering, and high-throughput screening for optimized tissue regeneration.</p>","PeriodicalId":100191,"journal":{"name":"BMEMat","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bmm2.12065","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140015104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emma Y. Yim, Amanda C. Zhou, Yvonne C. Yim, Xiang Wang, Tian Xia
While most nanomedicines primarily aim to stimulate the immune system against infections or tumors, there is a growing demand for inducing immune tolerance under certain conditions, such as allergic and autoimmune diseases. Researchers have explored nanotechnology-based strategies to induce immune tolerance in a targeted and specific manner. One approach involves the use of nanoparticles (NPs) to encapsulate immunosuppressive drugs and/or antigens to educate naïve T cells and promote the generation of antigen-specific regulatory T cells that inhibit immune responses. However, this approach has certain limitations. The hydrophobicity of proteins or peptides restricts the degree to which they can be encapsulated in NPs, which in turn, affects their loading efficiency and treatment efficacy. With the emergence of mRNA lipid nanoparticle (LNP) platforms, there is the possibility of overcoming the limitations of protein and peptide encapsulation. To date, mRNA LNP systems have been shown to provide organ, cellular, and subcellular targeting for the induction of immune tolerance. This method of drug delivery is flexible and scalable that can be customized for a specific patient, resulting in an effective means of administering relevant proteins or epitopes to induce antigen-specific immune tolerance. With continued research and development, this technology could offer a safer and more effective alternative to current therapies, ultimately improving the quality of life of patients worldwide.
虽然大多数纳米药物的主要目的是刺激免疫系统对抗感染或肿瘤,但在某些情况下,如过敏性疾病和自身免疫性疾病,对诱导免疫耐受的需求也在不断增长。研究人员探索了基于纳米技术的策略,以有针对性和特异性的方式诱导免疫耐受。其中一种方法是使用纳米颗粒(NPs)封装免疫抑制药物和/或抗原,以教育幼稚的 T 细胞,促进抑制免疫反应的抗原特异性调节性 T 细胞的生成。然而,这种方法有一定的局限性。蛋白质或肽的疏水性限制了它们被包裹在 NPs 中的程度,进而影响了它们的装载效率和治疗效果。随着 mRNA 脂质纳米粒子(LNP)平台的出现,有可能克服蛋白质和多肽封装的局限性。迄今为止,mRNA LNP 系统已被证明可为诱导免疫耐受提供器官、细胞和亚细胞靶向。这种给药方法具有灵活性和可扩展性,可为特定患者量身定制,从而成为给药相关蛋白质或表位以诱导抗原特异性免疫耐受的有效方法。随着研究和开发的不断深入,这项技术将为现有疗法提供更安全、更有效的替代方案,最终改善全球患者的生活质量。
{"title":"Antigen-specific mRNA lipid nanoparticle platforms for the prevention and treatment of allergy and autoimmune diseases","authors":"Emma Y. Yim, Amanda C. Zhou, Yvonne C. Yim, Xiang Wang, Tian Xia","doi":"10.1002/bmm2.12060","DOIUrl":"10.1002/bmm2.12060","url":null,"abstract":"<p>While most nanomedicines primarily aim to stimulate the immune system against infections or tumors, there is a growing demand for inducing immune tolerance under certain conditions, such as allergic and autoimmune diseases. Researchers have explored nanotechnology-based strategies to induce immune tolerance in a targeted and specific manner. One approach involves the use of nanoparticles (NPs) to encapsulate immunosuppressive drugs and/or antigens to educate naïve T cells and promote the generation of antigen-specific regulatory T cells that inhibit immune responses. However, this approach has certain limitations. The hydrophobicity of proteins or peptides restricts the degree to which they can be encapsulated in NPs, which in turn, affects their loading efficiency and treatment efficacy. With the emergence of mRNA lipid nanoparticle (LNP) platforms, there is the possibility of overcoming the limitations of protein and peptide encapsulation. To date, mRNA LNP systems have been shown to provide organ, cellular, and subcellular targeting for the induction of immune tolerance. This method of drug delivery is flexible and scalable that can be customized for a specific patient, resulting in an effective means of administering relevant proteins or epitopes to induce antigen-specific immune tolerance. With continued research and development, this technology could offer a safer and more effective alternative to current therapies, ultimately improving the quality of life of patients worldwide.</p>","PeriodicalId":100191,"journal":{"name":"BMEMat","volume":"2 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bmm2.12060","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139002169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In article number 10.1002/bmm2.12047, Ka Ram Kim and Woon-Hong Yeo have comprehensively summarized the recent advances in developing various sensors for enhanced monitoring of cellular physiological properties and metabolites with environmental conditions. This image shows the intracellular and extracellular environments that need to be monitored during cell culture processes.